Key result
Warfarin was associated with the highest risk for 30-day and 90-day postoperative complications following total hip arthroplasty, including an increased risk of 30-day DVT.
Why the study?
Do different VTE chemoprophylactic regimens have different rates of postoperative complications in patients undergoing total hip arthroplasty?
Cohort (n=25,966)
Yes
Do different VTE chemoprophylactic regimens have different rates of postoperative complications in patients undergoing total hip arthroplasty?
Answers are grounded in this paper and cite their sources.
In patients undergoing total hip arthroplasty, enoxaparin and rivaroxaban appear to offer better safety and efficacy profiles for VTE prophylaxis compared to warfarin.
Optimal prophylaxis for prevention of venous thromboembolism (VTE) after total joint arthroplasty (TJA) remains debated. The purpose of this study was to compare postoperative complications in patients receiving different VTE chemoprophylactic regimens. Using a nationwide healthcare database, 72,670 THA patients without a history of VTE were identified. Study cohorts received VTE prophylaxis within 30 days postoperatively. Odds ratios and 95% confidence intervals were used to assess 30-day and 90-day postoperative complications (hematoma, hemorrhage, transfusion, pulmonary embolism (PE), VTE, prosthetic joint infection (PJI), and incision/drainage (I&D)). Of the 72,670 THA patients, 25,966 received single medication VTE prophylaxis; 551 (2.12%) aspirin, 6791 (26.15%) enoxaparin, 12,008 (46.25%) warfarin, 5403 (20.81%) rivaroxaban, 876 (3.37%) fondaparinux and 337 (1.30%) apixaban. 30-day complications included; aspirin: I&D; warfarin: I&D, hematoma, hemorrhage, transfusion, PJI, PE and DVT; apixaban: hematoma and hemorrhage. 90-day complications included; aspirin: I&D; warfarin: I&D, hematoma, hemorrhage, transfusion, PJI, PE and DVT. Warfarin was the only anticoagulant associated with a higher risk for DVT, and the highest risk for 30-day and 90-day complications. Aspirin had the highest risk for I&D. Despite three times increased 30-day risk for bleeding, apixaban was effective in preventing VTE during the high-risk 3-month-period. Enoxaparin had the lowest risk for PE and DVT while rivaroxaban had the lowest risk for PJI, hematoma, I&D, hemorrhage and transfusion.
No takes yet. Share an insight, caveat, or question.
Agaba et al. (2017) conducted a cohort in Total hip arthroplasty (THA) (n=25,966). Warfarin vs. Other VTE prophylactic agents was evaluated on 30-day deep vein thrombosis (DVT) (OR 1.53, 95% CI 1.39-1.67, p=<0.05). Warfarin was associated with the highest risk for 30-day and 90-day postoperative complications following total hip arthroplasty, including an increased risk of 30-day DVT.
Synapse has enriched 10 related papers. Consider them for comparative context: